Annual Total Long Term Liabilities
$208.21 M
+$72.61 M+53.55%
December 31, 2024
Summary
- As of March 5, 2025, NTLA annual total long term liabilities is $208.21 million, with the most recent change of +$72.61 million (+53.55%) on December 31, 2024.
- During the last 3 years, NTLA annual total long term liabilities has risen by +$79.82 million (+62.17%).
- NTLA annual total long term liabilities is now at all-time high.
Performance
NTLA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$208.21 M
+$103.16 M+98.19%
December 31, 2024
Summary
- As of March 5, 2025, NTLA quarterly total long term liabilities is $208.21 million, with the most recent change of +$103.16 million (+98.19%) on December 31, 2024.
- Over the past year, NTLA quarterly long term liabilities has stayed the same.
- NTLA quarterly long term liabilities is now at all-time high.
Performance
NTLA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NTLA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.5% | 0.0% |
| 3 y3 years | +62.2% | +62.2% |
| 5 y5 years | +623.8% | +623.8% |
NTLA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.2% | at high | +98.2% |
| 5 y | 5-year | at high | +623.8% | at high | +623.8% |
| alltime | all time | at high | >+9999.0% | at high | +623.8% |
Intellia Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $208.21 M(+53.5%) | $208.21 M(+98.2%) |
| Sep 2024 | - | $105.05 M(-9.0%) |
| Jun 2024 | - | $115.38 M(-8.1%) |
| Mar 2024 | - | $125.54 M(-7.4%) |
| Dec 2023 | $135.60 M(-14.2%) | $135.60 M(+19.0%) |
| Sep 2023 | - | $113.98 M(-3.8%) |
| Jun 2023 | - | $118.50 M(-4.2%) |
| Mar 2023 | - | $123.66 M(-21.7%) |
| Dec 2022 | $157.98 M(+23.0%) | $157.98 M(+23.1%) |
| Sep 2022 | - | $128.38 M(+21.0%) |
| Jun 2022 | - | $106.12 M(-13.7%) |
| Mar 2022 | - | $122.92 M(-4.3%) |
| Dec 2021 | $128.39 M(+51.1%) | $128.39 M(-1.5%) |
| Sep 2021 | - | $130.30 M(+25.9%) |
| Jun 2021 | - | $103.47 M(-6.2%) |
| Mar 2021 | - | $110.32 M(+29.8%) |
| Dec 2020 | $85.00 M | $85.00 M(+16.3%) |
| Sep 2020 | - | $73.07 M(-8.8%) |
| Jun 2020 | - | $80.10 M(+152.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $31.69 M(+10.2%) |
| Dec 2019 | $28.77 M(-0.2%) | $28.77 M(-14.0%) |
| Sep 2019 | - | $33.46 M(-9.8%) |
| Jun 2019 | - | $37.11 M(-9.0%) |
| Mar 2019 | - | $40.79 M(+41.5%) |
| Dec 2018 | $28.82 M(-34.9%) | $28.82 M(-10.1%) |
| Sep 2018 | - | $32.05 M(-9.1%) |
| Jun 2018 | - | $35.27 M(-8.3%) |
| Mar 2018 | - | $38.46 M(-13.1%) |
| Dec 2017 | $44.28 M(-24.2%) | $44.28 M(-6.9%) |
| Sep 2017 | - | $47.54 M(-6.8%) |
| Jun 2017 | - | $51.02 M(-6.3%) |
| Mar 2017 | - | $54.47 M(-6.7%) |
| Dec 2016 | $58.40 M(-37.0%) | $58.40 M(-3.8%) |
| Sep 2016 | - | $60.71 M(-7.2%) |
| Jun 2016 | - | $65.41 M(-28.7%) |
| Mar 2016 | - | $91.72 M(-1.0%) |
| Dec 2015 | $92.64 M(>+9900.0%) | $92.64 M |
| Dec 2014 | $773.00 K | - |
FAQ
- What is Intellia Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Intellia Therapeutics?
- What is Intellia Therapeutics annual total long term liabilities year-on-year change?
- What is Intellia Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly long term liabilities year-on-year change?
What is Intellia Therapeutics annual total long term liabilities?
The current annual total long term liabilities of NTLA is $208.21 M
What is the all time high annual total long term liabilities for Intellia Therapeutics?
Intellia Therapeutics all-time high annual total long term liabilities is $208.21 M
What is Intellia Therapeutics annual total long term liabilities year-on-year change?
Over the past year, NTLA annual total long term liabilities has changed by +$72.61 M (+53.55%)
What is Intellia Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of NTLA is $208.21 M
What is the all time high quarterly long term liabilities for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly total long term liabilities is $208.21 M
What is Intellia Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, NTLA quarterly total long term liabilities has changed by $0.00 (0.00%)